Endolymphatic Sac Decompression Effective for Vertigo, Migraine
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and migraine, according to a study published online April 30 in Acta Oto-Laryngologica.
Lin Han, from Peking University in Beijing, and colleagues enrolled 104 MD patients to examine the relation of MD and migraine. To assess effectiveness at pre- and post-ELSD, monthly vertigo episodes and the migraine headache index were used. Vertigo relief rates were compared for patients divided into MD with migraine and MD alone; postoperative relief of vertigo and migraine was then assessed in MD patients with migraine.
The researchers found that the postoperative vertigo relief rates were 46.7 and 40.68 percent for MD alone and MD with migraine, respectively, with no significant difference noted. Postoperative monthly vertigo episodes and the migraine headache index decreased significantly in MD patients with migraine. The kappa value was 0.505 for vertigo and migraine outcomes. Independent predictive relief of vertigo and migraine was seen with the absence of hypertension. Male gender was independently predictive for migraine relief.
"The postoperative relief of vertigo and migraine has a certain consistency, suggesting that these two diseases may share some common pathogenesis related to inflammation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
Pediatric Magnet Ingestion Rates Still High
THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.